type 11-like cells thus accounting for a slight (25%) increase in the synthesis of surfactant. Continual epithelial thickening and the synthesis and secretion of surfactant with an unaltered rate of removal would lead to accumulation of the lipoprotein at the lung surface.
Isolated alveolar type I1 cells: a model for studies on the formation of surfactant dipalmitoylphospha tid ylcholine
LAMBERT M. G. VAN The alveolar surfaces of the lung are lined with pulmonary surfactant. This material has the ability to reduce the surface tension at the alveolar epithelium-air interface, thus preventing flooding of the airspaces and collapse of the alveoli at end-expiration. The major determinant of the surface-tension-lowering properties of surfactant is dipalmitoylphosphatidylcholine (Clements, 1977) . Surfactant appears to be involved also in several defence mechanisms of vital importance. These include centripetal non-ciliary transport of foreign particles, phagocytosis of inhaled particles and bacteria, and ciliar transport of mucus (for a review see Robertson & Van Golde, 1984) . Radioautographic studies (Chevalier & Collet, 1972 ) have shown that alveolar surfactant is produced exclusively by the alveolar type I1 cell, which is one of the approx.
40 different cell types in lung tissue. It is the purpose of this paper to briefly review the contribution of studies with isolated type I1 pneumocytes to our current understanding of surfactant lipid biosynthesis. The discussion will be focused on the formation of dipalmitoylphosphatidylcholine.
Isolation of alveolar type II cells
Virtually pure preparations of type I1 pneuniocytes can now be obtained from adult lung after proteolytic digestion with trypsin or elastase, followed by gradient centrifugation and either differential adherence in primary culture or centrifugal elutriation . Dobbs el al. (1982) showed that the material secreted from rat type I1 cells after 1 day in primary culture was similar chemically and physically to surfactant obtained by endobronchial lavage. Furthermore, it was similar morphologically to the surfactant material seen in the alveoli of rats. Recently, Post et al. ( 1 9 8 4~) reported a method to obtain a relatively pure (83%) preparation of type I1 cells from fetal rat lung.
Abbreviation used: DTNB, 5,5'dithiobis(2-nitrobenzoic acid).
Formation of dipalmitoylphosphatidylcholine by direct synthesis de novo
The synthesis de novo of phosphatidylcholine starts with the formation of phosphatidic acid. Studies with wholelung microsomes and mitochondria (Yamada & Okuyama, 1979) suggested that the acylation of glycerol 3-phosphate proceeds stepwise with 1 -acyl-glycerol 3-phosphate as intermediate. Recently, we began studies on the glycerolphosphate acyltransferase system in rat type I1 cells that had been in primary culture for 24 h. Microsomes prepared either from these type I1 cells or from whole rat lung were incubated with radioactively labelled glycerol 3-phosphate and either unlabelled palmitoyl-CoA or oleoyl-CoA. The product of the reaction appeared t o be mainly phosphatidic acid. Fig. 1 shows that the conversion of glycerol 3-phosphate into phosphatidic acid is more active in microsomes from type I1 cells than in microsomes from whole lung.
A similar finding was recently reported for freshly isolated type I1 cells from rabbit lung (Finkelstein et al., 1983 ).
There was not much difference between the incorporation of glycerol 3-phosphate in the presence of palmitoyl-CoA as acyl-donor and that measured with oleoyl-CoA. We also investigated the subcellular distribution of glycerol 3-phosphate acylation in type I1 cells. The distribution almost paralleled that of the microsomal marker NADPH-cytochrome c reductase. This indicates that the acylation of glycerol 3-phosphate occurs in the type 11 cell predominantly in the endoplasmic reticulum. The marker enzyme data suggested that only 5-10% of the total glycerol 3-phosphate acylation activity of type I1 cells resides in the mitochondria. Earlier studies with whole lung (Yamada & Okuyama, 1979) showed that the SH-reagent 5,5'-dithiobis-(2-nitrobenzoic acid) (DTNB) inhibits microsomal glycerolphosphate acyltransferase whereas it does not affect the mitochondria1 enzyme. Fig. 2 shows that indeed only a minor fraction of glycerolphosphate acylation activity of type 11 cells is insensitive to DTNB. Interestingly, this DTNB-insensitive activity, which is presumably of mitochondrial origin, did not utilize oleoyl-CoA as substrate. With palmitoyl-CoA, monoacyl-glycerol 3-phosphate accumulated as the major product.
Incubation of microsomes from type 11 cells with unlabelled glycerol 3-phosphate and an equimolar mixture of palmitoyl-CoA and oleoyl-CoA (one of which was Vol. 13 Type I1 cells were isolated from adult rat lung as described earlier (Batenburg et al., 1979) . Microsomes from type I1 cells (21pg of protein) and microsomes from whole rat lung (143 pg of protein) were incubated for 8 min at 30°C in 150 p1 of medium of the following composition: 1.5 mM- radioactively labelled), resulted in random incorporation of both palmitate and oleate into the 1-and 2-position of of phosphatidic acid. These preliminary experiments would suggest that type I1 cell microsomes have the potential to synthesize phosphatidic acid with a significant proportion of dipalmitoyl-species. However, it should be realized that such experiments do not rule out the possibility that the radioactive fatty acids were incorporated into phosphatidic acid by acylation of endogenous monoacylglycerol-3-phosphate (i.e. monoacyl-glycerol 3-phosphate not originating from the added glycerol 3-phosphate).
The synthesis of phosphatidylcholine continues with the conversion of phosphatidic acid into diacylglycerol by phosphatidic acid phosphatase. Investigations on the substrate specificity of this enzyme in type I1 cells (Crecelius & Longmore, 1983 ) demonstrated that it did not discriminate between emulsions of dipalmitoylphosphatidic acid and unsaturated phosphatidic acids.
The last step in the synthesis de novo of phosphatidylcholine is catalysed by cholinephosphotransferase. Studies with sonicated type I1 cells using endogenous diacylglycerols as substrate (Post et al., 1983) and experiments with type I1 cell microsomes using exogenous diacylglycerols as substrate (Crecelius & Longmore, 1984b) showed that cholinephosphotransferase utilizes disaturated diacylglycerols equally well as unsaturated diacylglycerols. The substrate specificity of the glycerolphosphate acyltransferase system, phosphatidic acid phosphatase and cholinephosphotransferase, would seem compatible with the ability of type I1 cells to synthesize dipalmitoylphosphatidylcholine by direct synthesis de novo. Fig. 2 . Acylation of glycerol 3-phosphate by type II cell sonicates in the absence and presence o f DTNB Sonicates of type I1 cells were prepared as described earlier (Batenburg et al., 1979) . Type I1 cell sonicates ( 6 0 p g of protein) were incubated in the absence ( a ) or presence ( b ) of 4mM-DTNB in 15Op1 of a medium with the same composition as that described in the legend to Fig. 1 , with the exception that the glycerol 3-phosphate concentration was 92 pM. After 8 min incubation at 30°C the reactions were terminated and radioactivity incorporated into lipids was estimated. In the absence of DTNB, phosphatidic acid was the major labelled product; in the presence of DTNB, acyl-glycerol 3-phosphate was the major labelled product (see text).
In addition to diacylglycerols, cholinephosphot ransferase also requires CDP-choline. This liponucleotide is synthesized from choline by the sequential action of choline kinase and cholinephosphate cytidylyltransferase. Recent experiments with type I1 cells isolated from adult (Post et al., 1982 (Post et al., , 1984a or fetal (Post et al., 19848) rat lung provided strong evidence that cholinephosphate cytidylyltransferase catalyses the rate-limiting step in the conversion of choline into phosphatidylcholine.
Formation of dipalmitoylphosphatidylcholine by remodelling of unsaturated phosphatidylcholines
Studies with type I1 cells provided evidence that dipalmitoylphosphatidylcholine is not only produced by direct synthesis de novo, but also by remodelling of unsaturated phosphatidylcholines. Labelled palmitate was incorporated preferentially into the 2-position of disaturated phosphatidylcholine (which is mostly dipalmitoylphosphatidylcholine), but equally into the 1 -and 2-positions of disaturated diacylglycerols (Post et al., 1983; Mason & Nellenbogen, 1984) . The accumulation of labelled palmitate at the 2-position of disaturated phosphatidylcholine cannot be explained if disaturated phosphatidylcholine were synthesized entirely from disaturated diacylglycerols. Pulse and pulse-chase experiments with type I1 cells (Mason and Nellenbogen, 1984) showed that unsaturated phosphatidylcholine species are indeed converted into disaturated phosphatidylcholine.
The major mechanisms that have been proposed for the remodelling of phosphatidylcholines that contain a palmitate at position-I and an unsaturated fatty acid at position-2 are: (a) a deacylation-reacylation cycle and (b) a deacylation-transacylation process. Both mechanisms require the removal of the unsaturated fatty acid from the 2-position, most likely by a phospholipase A*. In mechanism (a) the vacant OH-group at position-2 is esterified with palmitate by lysophosphatidylcholine acyltransferase. In mechanism 613th MEETING, CARDIFF (b) a transacylation occurs between two molecules of 1 -palmitoyl-glycero-3-phosphocholine. Studies with type I1 cells from adult lung (Batenburg et al. 1979; Finkelstein et al., 1983; Crecelius & Longmore, 1984a) and from fetal lung (De Vries et al., 1985) have shown that lysophosphatidylcholine acyltransferase is enriched in type I1 cells when compared with whole lung. Moreover, the type I1 cell enzyme preferentially utilizes palmitoyl-CoA over unsaturated CoA-esters (Batenburg et al., Crecelius & Longmore, 1984a) . On the other hand, the activity of the enzyme catalysing the transacylation appeared to be very low in type I1 cells from adult and fetal lung. These results strongly suggest that deacylation-reacylation is much more important for the remodelling of unsaturated phosphatidylcholines in the type I1 cell than deacylationtransacylation.
Conclusion
The results obtained so far suggest that the biosynthesis of dipalmitoylphosphatidylcholine in the type I1 cell can proceed both by direct synthesis de novo and by remodelling of unsaturated phosphatidylcholines, most likely via a deacylation-reacylation process. The relative importance of these two processes in uivo is difficult to assess. One of the difficulties of interpreting the results of the many studies on this subject is that increased synthesis of pulmonary surfactant is seldom distinguished from an increased rate of release. Both processes are stimulated by fl-adrenergic agonists but this discussion will be concerned chiefly with surfactant release from the type I1 alveolar cell, where surfactant is synthesized and stored intracellularly in osmiophillic lamellar bodies. fl-Adrenergic action is only one of several stimuli which have been implicated in surfactant release. Others include prostaglandins of the E series (Marino & Rooney, 1981; Oyarzun & Clements, 1978) , cholinergic agents (Corbet et al., 1976; Oyarzun & Clements, 1977; Brown & Longmore, 198 1) and distention (stretch) of the alveolar epithelium (Faridy, 1976; Oyarzun & Clements, 1977; Lawson et al., 1978; Nicholas & Barr, 1983; Corbet et al., 1983) . Adrenaline, the natural 0-agonist, appears to have an important physiological role at the time of birth in ensuring the establishment of adequate air breathing. It is also likely to be involved in sympathetic nervous system stress reactions during which hyperventilation occurs. The latter process is thought to consume the surfactant monolayer at the air-liquid interface faster than normal and would thus create the demand for increased amounts of alveolar surfactant.
The process of labour and birth is associated with very high fetal blood concentrations of catecholamines (Brown et al., 1983; Lagercrantz et al., 1981) and clinical data Vol. 13 indicate that fetuses exposed to labour, regardless of whether they are subsequently born vaginally or not, have a reduced incidence of hyaline membrane disease when compared with fetuses born by Caesarean section who have not undergone labour (Frederick & Butler, 1972) . However, the exposure to adrenaline during labour is over hours and clearly it is impossible to attribute any benefit of labour solely to surfactant release. Indeed, not only is surfactant synthesis likely to be stimulated by adrenaline (Kanjanapore et al., 1980; Mettler et al., 1981) and perhaps by other hormones but there will be rapid removal of fetal lung liquid, a process also brought about by adrenaline stimulation (Brown et al., 1983) which will result in improved lung compliance and thus better gas exchange.
Although Enhorning et al. (1977) exposed rabbit fetuses to isoxuprine for over 4 h they concluded that there must have been release of surfactant because there was, on average, a decreased number of lamellar bodies in the type I1 cells of treated fetuses compared with controls. They also demonstrated higher phosphatidylcholine/ sphingomyelin ratios, lower minimum surface tension measurements of lung liquid and a decreased lung weight in treated fetuses. The decrease in type I1 cell lamellar body number has since been shown to occur within 3 0 s of fl-agonist exposure (Tsilibary & Williams, 13833) .
The debate in the literature over whether cholinergic agents have a direct effect in causing surfactant release in whole lungs or whether they act indirectly by releasing adrenaline from the adrenal medulla or from sympathetic nerves in the lung has not yet been conclusively resolved.
